Project Score database: a resource that will help designing the next generation of anti-cancer drugs
A new paper published by Nuclear Acids Research and co-authored by Francesco Iorio, Group Leader at the Centre for Computational Biology, describes the creation of Project Score: a web portal enabling users to estimate the potential of each gene as a therapeutic target of future anti-cancer drugs.
Project Score, created and maintained by the group of Mathew Garnett at the Wellcome Sanger Institute, allows to browse data, download free datasets, and investigate specific biological hypotheses. For example, by specifying the name of any gene, the system will offer additional information on the gene’s target-priority score, potential biomarkers and tractability, including whether there are already drugs available to inhibit the corresponding coded protein.
The data underlying this resource has been made available thanks to CRISPR Cas9 whole-genome drop out screens which allow to better understand gene function and identify dependencies in cancer cells. The system is based on a computational pipeline developed by Francesco Iorio, Fiona Behan and Mathew Garnett and data described in a paper published last year in Nature, as part of the Cancer Dependency Map initiative.
Share:
You could also like:
-
HT National Facilities: Upcoming Call for Access 2025 – Round 2
On 27 and 28 March, the SIEC (Standing Independent Evaluation Committee), visited HT to discuss the results of the first call for access, which was considered a pilot phase, and refine the upcoming call, planned to be published at the beginning of June 2025.
-
HT PhD Student & Postdoc Symposium 2025: “Research in Motion”
After the success of its inaugural edition, which gathered over 100 participants, the HT PhD Student & Postdoc Symposium returns for its second year on 30 September 2025. Join us in supporting the future of life sciences. Every contribution can make a difference!
-
Cancer, insomnia, ancient DNA: over 100 projects from Italian scientists at HT
Human Technopole has presented 102 research projects that were the first to benefit from the cutting-edge equipment of the National Facilities — the advanced technologies that the Institute makes available to external researchers from across Italy. The majority of studies focus on cancer and neurodegenerative diseases, accounting for 50% of the selected projects. The announcement was made this morning in Milan during “Open HT – The Open Day on Life Sciences”, an event designed to showcase Human Technopole’s achievements and outline future goals.
-
10 Fully Funded PhD Scholarships in Systems Medicine through SEMM
Human Technopole is offering up to 10 fully funded PhD scholarships through the SEMM PhD Program in Systems Medicine. These scholarships are open to talented and motivated graduates—both from Italy and abroad – interested in pursuing doctoral research.
-
Human Technopole Commitment to Gender Equality
Human Technopole is proud to announce the launch of its new Gender Equality Plan (GEP) for 2025-2027, a strategic initiative designed to further integrate gender equality across all aspects of the Institute, building upon the successful outcomes of the previous GEP (2022-2024). HT has also achieved the UNI/PdR 125:2022 certification, which recognizes organizations that promote gender equality and foster inclusive workplaces.